疼痛障碍

  • 网络pain disorder;pspd
疼痛障碍疼痛障碍
  1. 目的探讨持续性躯体形式疼痛障碍(persistsomatoformpaindisorder,PSPD)患者的生命质量及相关因素。

    Objective : To explore the quality of life of patients with persist somatoform pain disorder ( PSPD ) and its relative factors .

  2. 文拉法辛缓释剂治疗躯体形式疼痛障碍疗效观察

    Effect of venlafaxine XR in the treatment of persistent somatoform pain disorder

  3. E富尔马克认为,这类基因的作用也适用于其他与扁桃核有关的疾病,如恐惧症、疼痛障碍、忧郁症等。

    Furmark believes the effect of the gene may extend to other conditions where the amygdala is involved , such as phobias , pain disorders and even depression .

  4. 氟西汀治疗持续性躯体形式疼痛障碍疗效观察

    Curative effects of fluoxetine in persistent somatoform pain disorder

  5. 持续的躯体形式的疼痛障碍患者的防御机制及相关因素研究

    Defense Mechanism and Its Related Factors in Patients with Persistent Somatoform Pain Disorder

  6. 氟西汀治疗持续的躯体形式的疼痛障碍的疗效及其作用机制

    Efficacy of fluoxetine and its mechanism for patients with persist somatoform pain disorder

  7. 持续性躯体形式疼痛障碍生命质量的相关因素研究

    A preliminary study of factors of life quality in patients with persist somatoform pain disorder

  8. 持续的躯体形式疼痛障碍患者抑郁症状的特征及治疗

    Effect of Fluoxetine in Treatment of Anxiety and Depression of Patients with Persistent Somatoform Pain Disorder

  9. 目的研究帕罗西汀对持续的躯体形式疼痛障碍(以下简称持续疼痛障碍)的疗效。

    Objective To study the efficacy of paroxetine in the patients with persist somatoform pain disorder .

  10. 目的:观察文拉法辛治疗持续性躯体形式疼痛障碍的疗效。

    Objective : To survey the therapeutic effectiveness of venlafaxine in the treatment of persistent somatoform pain disorder .

  11. 目的:对持续的躯体形式的疼痛障碍(以下简称持续疼痛障碍)患者的心理防御机制及相关因素进行研究。

    Objective : To explore psychological defense mechanism and its related factors in patients with persistent somatoform pain disorder .

  12. 方法对62例持续性躯体形式疼痛障碍患者应用氟西汀20mg。

    Methods 62 patients with persistent somatoform pain disorder were treated with fluoxetine hydrochloride 20mg / d for 6 weeks .

  13. 结论氟西汀治疗持续性躯体形式疼痛障碍疗效显著,安全性高,依从性好。

    Conclusion Fluoxetine hydrochloride has notable efficacy , higher safety and better compliance in the treatment of persistent somatoform pain disorder .

  14. 结论:文拉法辛对持续性躯体形式疼痛障碍疗效好,不良反应小,安全性高。

    Conclusion : Venlafaxime was shown to be fairly effective and safe in the treatment of persistent somatoform pain disorder , with a low incidence of adverse reactions .

  15. 结果(1)持续的躯体形式的疼痛障碍最常见于头部、背部及四肢,疼痛性质多与疼痛部位有关;

    Results : ( 1 ) Head and back was more frequent area of pain , and the characteristic of pain is related to the area of pain ;

  16. 应用疼痛控制障碍问卷(BQ)测量患者对疼痛治疗的顾虑。

    The Barrier Questionnaire ( BQ ) and the Compliance Questionnaire were used in this study .

  17. 恶化、死亡的24例SAH以<45岁、出血后14d内多见,多以后枕部疼痛、意识障碍为首发症状,后颅窝出血为常见出血部位。

    Occiput pain and conscious disturbance was mainly the first symptoms of aggravation and death of SAH which happened in 14 days after hemorrhage and under 45 year ages .

  18. 身体症状(例如,疼痛和睡眠障碍)

    Physical symptoms ( e.g.aches and sleep disturbance )

  19. 长期生存质量主要影响因素是有无疼痛、情绪障碍及活动功能。

    Long-term quality of life is dominated by pain , mood disorders and moderate mobility problems .

  20. 银屑病性关节炎是一种炎性关节病,能导致僵硬、疼痛和运动障碍。

    Psoriatic arthritis is an inflammatory joint disease which can cause stiffness , pain and lack of movement .

  21. 临床表现为关节对称性疼痛、运动障碍、甚至关节强直畸形致残,以及多脏器受累。

    The clinical manifestations include symmetric arthralgia , movement dysfunction , even rigid joint deformation , disability and involvement of multiple organs .

  22. 目的:分析慢性疼痛与情绪障碍之间的关系,探讨心理及药物治疗对慢性疼痛的干预作用。

    OBJECTIVE : To analyze the relationship between chronic pain and pain-prone mental disorders and investigate the effect of psychological intervention and medication .

  23. 肩手综合征是指脑血管病并发的肩、手疼痛和运动障碍。

    Humeral hand is asked for integratedly is to show cerebral blood-vessel disease is concurrent ache of shoulder , hand and athletic obstacle .

  24. 外科治疗对于下肢无力、步态异常、疼痛和感觉障碍效果较好,对于大小便功能障碍效果不理想。

    Surgical therapy effect on leg weakness , gait abnormality , pain , and sensory disability was better than urination and defecation function disturbance .

  25. 颈椎后凸畸形可能是失衡现象中最影响功能的,因为它可以导致疼痛、姿势障碍以及神经系统症状。

    Cervical kyphosis may represent the most disabling of these imbalances , for it can cause pain , postural difficulties , or neurologic deficit .

  26. 与对照组比较,治疗组对疲劳、咽痛、肌肉疼痛、睡眠障碍及运动后疲劳等症状改善明显(P<0.05)。

    Compared with the control group , the clinical symptoms of the treating group , including fatigue , pharyngalgia , muscular soreness , sleep disorder and postexercise fatigue , were all significantly improved ( P < 0.05 ) .

  27. 分别在治疗前、治疗中、治疗后观察受试者的视觉模拟评分法(VAS)、踝关节扭伤症状积分(ASI),包括关节疼痛指数、关节障碍指数、关节肿胀、关节红热等情况。

    Respectively before treatment , after treatment . The trial observed the subjects ' visual analogue scale ( VAS ), ankle sprains symptom integral ( ASI ), including joint pain , joint disorders index , joint swelling , joint red , and so on and so forth .

  28. 结论股骨髁间窝狭窄是引起膝关节疼痛及伸膝障碍的重要原因之一,术中应常规检查。

    Conclusion Intercondylar notch stenosis was one of the main causes for limited movement of knee joint and swelling .

  29. 探索慢性疼痛病人抑郁性障碍和焦虑性障碍的严重程度与痛知觉阈值改变的相关性。

    Objective To explore the correlation among depressive and / or anxiety disorder and pain perception threshold on chronic pain patients .

  30. 目的:观察曲唑酮与止痛剂对持续性疼痛性躯体形式障碍的疗效与副反应。

    Objective : To observe the effects and side-effects of trazodone ( TZD ) and analgesic ibuprofen ( PRF ) in the treament of persistent somatoform pain disorder .